|
|
|
|||||||
|
|||||||||
J Biol Chem, Vol. 274, Issue 50, 35461-35468, December 10, 1999
From the Department of Pathology and Laboratory Medicine,
University of Pennsylvania School of Medicine,
Philadelphia, Pennsylvania 19104
Prolactin-dependent signaling occurs
as the result of ligand-induced dimerization of the prolactin receptor
(PRLr). While three PRLr isoforms have been characterized in the rat,
studies have suggested the existence of several human isoforms in
breast carcinoma species and normal tissues. Reverse transcription
polymerase chain reaction was performed on mRNA isolated from the
breast carcinoma cell line T47D, revealing two predominant receptor
isoforms: the previously described long PRLr and a novel human
intermediate PRLr. The nucleotide sequence of the intermediate isoform
was found to be identical to the long isoform except for a 573-base pair deletion occurring at a consensus splice site, resulting in a
frameshift and truncated intracytoplasmic domain. Scatchard analysis of
the intermediate PRLr revealed an affinity for PRL comparable with the
long PRLr. While Ba/F3 transfectants expressing the long PRLr
proliferated in response to PRL, intermediate PRLr transfectants
exhibited modest incorporation of [3H]thymidine.
Significantly, however, both the long and intermediate PRLr were
equivalent in their inhibition of apoptosis of the Ba/F3 transfectants
after PRL treatment. The activation of proximal signaling molecules
also differed between isoforms. Upon ligand binding, Jak2 and Fyn were
activated in CHO-K1 cells transiently transfected with the long PRLr.
In contrast, the intermediate PRLr transfectants showed equivalent
levels of Jak2 activation but only minimal activation of Fyn. Last,
Northern analysis revealed variable tissue expression of intermediate
PRLr transcript that differed from that of the long PRLr. Taken
together, differences in signaling and tissue expression suggest that
the human intermediate PRLr differs from the long PRLr in physiological function.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF166329.
Functional Characterization of the Intermediate Isoform of the
Human Prolactin Receptor*
*
This study was supported in part by the National Institutes
of Health grants 2R01CA69294 (to C. V. C.) and 1F32DK09727 (to J. B. K.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Pathology & Laboratory Medicine, University of Pennsylvania Medical Center, 509 Stellar-Chance Labs, 422 Curie Blvd., Philadelphia, PA 19104. E-mail:
clevengc@mail.med.upenn.edu.
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  Y.-L. Xie, S. A. Hassan, A. M. Qazi, C. H. Tsai-Morris, and M. L. Dufau Intramolecular Disulfide Bonds of the Prolactin Receptor Short Form Are Required for Its Inhibitory Action on the Function of the Long Form of the Receptor Mol. Cell. Biol., May 15, 2009; 29(10): 2546 - 2555. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. D. Galsgaard, B. B. Rasmussen, C. G. Folkesson, L. M. Rasmussen, M. W. Berchtold, L. Christensen, and S. Panina Re-evaluation of the prolactin receptor expression in human breast cancer J. Endocrinol., April 1, 2009; 201(1): 115 - 128. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Dail, L. A. Shack, J. E. Chambers, and S. C. Burgess Global Liver Proteomics of Rats Exposed for 5 Days to Phenobarbital Identifies Changes Associated with Cancer and with CYP Metabolism Toxicol. Sci., December 1, 2008; 106(2): 556 - 569. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J Brennan, J. A Sharp, E. Khalil, M. R Digby, S. L Mailer, C. M Lefevre, and K. R Nicholas A population of mammary epithelial cells do not require hormones or growth factors to survive J. Endocrinol., March 1, 2008; 196(3): 483 - 496. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Ben-Jonathan, C. R. LaPensee, and E. W. LaPensee What Can We Learn from Rodents about Prolactin in Humans? Endocr. Rev., February 1, 2008; 29(1): 1 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M A Hyatt, G S Gopalakrishnan, J Bispham, S Gentili, I C McMillen, S M Rhind, M T Rae, C E Kyle, A N Brooks, C Jones, et al. Maternal nutrient restriction in early pregnancy programs hepatic mRNA expression of growth-related genes and liver size in adult male sheep J. Endocrinol., January 1, 2007; 192(1): 87 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Gadd and C. V. Clevenger Ligand-Independent Dimerization of the Human Prolactin Receptor Isoforms: Functional Implications Mol. Endocrinol., November 1, 2006; 20(11): 2734 - 2746. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Qazi, C.-H. Tsai-Morris, and M. L. Dufau Ligand-Independent Homo- and Heterodimerization of Human Prolactin Receptor Variants: Inhibitory Action of the Short Forms by Heterodimerization Mol. Endocrinol., August 1, 2006; 20(8): 1912 - 1923. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-C. Lu, T. M. Piazza, and L. A. Schuler Proteasomes Mediate Prolactin-induced Receptor Down-regulation and Fragment Generation in Breast Cancer Cells J. Biol. Chem., October 7, 2005; 280(40): 33909 - 33916. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Gutzman, S. E. Nikolai, D. E. Rugowski, J. J. Watters, and L. A. Schuler Prolactin and Estrogen Enhance the Activity of Activating Protein 1 in Breast Cancer Cells: Role of Extracellularly Regulated Kinase 1/2-Mediated Signals to c-fos Mol. Endocrinol., July 1, 2005; 19(7): 1765 - 1778. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Tan, D. A. Johnson, W. Wu, L. Zeng, Y. H. Chen, W. Y. Chen, B. K. Vonderhaar, and A. M. Walker Unmodified Prolactin (PRL) and S179D PRL-Initiated Bioluminescence Resonance Energy Transfer between Homo- and Hetero-Pairs of Long and Short Human PRL Receptors in Living Human Cells Mol. Endocrinol., May 1, 2005; 19(5): 1291 - 1303. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Gutzman, D. E. Rugowski, M. D. Schroeder, J. J. Watters, and L. A. Schuler Multiple Kinase Cascades Mediate Prolactin Signals to Activating Protein-1 in Breast Cancer Cells Mol. Endocrinol., December 1, 2004; 18(12): 3064 - 3075. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Meng, C.-H. Tsai-Morris, and M. L. Dufau Human Prolactin Receptor Variants in Breast Cancer: Low Ratio of Short Forms to the Long-Form Human Prolactin Receptor Associated with Mammary Carcinoma Cancer Res., August 15, 2004; 64(16): 5677 - 5682. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Li, K. G. Suresh Kumar, W. Tang, V. S. Spiegelman, and S. Y. Fuchs Negative Regulation of Prolactin Receptor Stability and Signaling Mediated by SCF{beta}-TrCP E3 Ubiquitin Ligase Mol. Cell. Biol., May 1, 2004; 24(9): 4038 - 4048. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Schroeder, J. L. Brockman, A. M. Walker, and L. A. Schuler Inhibition of Prolactin (PRL)-Induced Proliferative Signals in Breast Cancer Cells by a Molecular Mimic of Phosphorylated PRL, S179D-PRL Endocrinology, December 1, 2003; 144(12): 5300 - 5307. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Olayioye, M. A. Guthridge, F. C. Stomski, A. F. Lopez, J. E. Visvader, and G. J. Lindeman Threonine 391 Phosphorylation of the Human Prolactin Receptor Mediates a Novel Interaction with 14-3-3 Proteins J. Biol. Chem., August 29, 2003; 278(35): 32929 - 32935. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. G. Sheffield and J. J. Gavinski Proteomics Methods for Probing Molecular Mechanisms in Signal Transduction J Dairy Sci, July 1, 2003; 86(13_suppl): E115 - 124. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Ling, L. Svensson, B. Oden, B. Weijdegard, B. Eden, S. Eden, and H. Billig Identification of Functional Prolactin (PRL) Receptor Gene Expression: PRL Inhibits Lipoprotein Lipase Activity in Human White Adipose Tissue J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1804 - 1808. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.M. Hair, F. C.W. Wu, and G. A. Lincoln An investigation of the effectiveness of testosterone implants in combination with the prolactin inhibitor quinagolide in the suppression of spermatogenesis in men Hum. Reprod., April 1, 2003; 18(4): 749 - 755. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. G. Sheffield and J. J. Gavinski Proteomics methods for probing molecular mechanisms in signal transduction J Anim Sci, March 1, 2003; 81(suppl_3): 48 - 57. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. V. Clevenger, P. A. Furth, S. E. Hankinson, and L. A. Schuler The Role of Prolactin in Mammary Carcinoma Endocr. Rev., February 1, 2003; 24(1): 1 - 27. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-C. Lu, P. Scott, G. J. Strous, and L. A. Schuler Multiple Internalization Motifs Differentially Used by Prolactin Receptor Isoforms Mediate Similar Endocytic Pathways Mol. Endocrinol., November 1, 2002; 16(11): 2515 - 2527. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Kline, M. A. Rycyzyn, and C. V. Clevenger Characterization of a Novel and Functional Human Prolactin Receptor Isoform ({Delta}S1PRLr) Containing Only One Extracellular Fibronectin-Like Domain Mol. Endocrinol., October 1, 2002; 16(10): 2310 - 2322. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.M. Hair, O. Gubbay, H.N. Jabbour, and G.A. Lincoln Prolactin receptor expression in human testis and accessory tissues: localization and function Mol. Hum. Reprod., July 1, 2002; 8(7): 606 - 611. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Rycyzyn and C. V. Clevenger The intranuclear prolactin/cyclophilin B complex as a transcriptional inducer PNAS, May 1, 2002; (2002) 92160699. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Schroeder, J. Symowicz, and L. A. Schuler PRL Modulates Cell Cycle Regulators in Mammary Tumor Epithelial Cells Mol. Endocrinol., January 1, 2002; 16(1): 45 - 57. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Ben-Jonathan and R. Hnasko Dopamine as a Prolactin (PRL) Inhibitor Endocr. Rev., December 1, 2001; 22(6): 724 - 763. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Gill, D Peston, B K Vonderhaar, and S Shousha Expression of prolactin receptors in normal, benign, and malignant breast tissue: an immunohistological study J. Clin. Pathol., December 1, 2001; 54(12): 956 - 960. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. P. Vlahos, E. M. Bugg, M. J. Shamblott, J. Y. Phelps, J. D. Gearhart, and H. A. Zacur Prolactin receptor gene expression and immunolocalization of the prolactin receptor in human luteinized granulosa cells Mol. Hum. Reprod., November 1, 2001; 7(11): 1033 - 1038. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C V Clevenger and J B Kline Prolactin receptor signal transduction Lupus, October 1, 2001; 10(10): 706 - 718. [Abstract] [PDF]
|
|
|
|
|
|
R Hooghe, Z Dogusan, N Martens, B Velkeniers, and E L Hooghe-Peters Effects of prolactin on signal transduction and gene expression: possible relevance for systemic lupus erythematosus Lupus, October 1, 2001; 10(10): 719 - 727. [Abstract] [PDF]
|
|
|
|
 |
|
 C. H. Lee and A. M. Edwards Stimulation of DNA synthesis and c-fos mRNA expression in primary rat hepatocytes by estrogens Carcinogenesis, September 1, 2001; 22(9): 1473 - 1481. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Kline, D. J. Moore, and C. V. Clevenger Activation and Association of the Tec Tyrosine Kinase with the Human Prolactin Receptor: Mapping of a Tec/Vav1-Receptor Binding Site Mol. Endocrinol., May 1, 2001; 15(5): 832 - 841. [Abstract] [Full Text]
|
|
|
|
|
|
Z.-Z. Hu, J. Meng, and M. L. Dufau Isolation and Characterization of Two Novel Forms of the Human Prolactin Receptor Generated by Alternative Splicing of a Newly Identified Exon 11 J. Biol. Chem., October 26, 2001; 276(44): 41086 - 41094. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |